• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Association of coagulation dysfunction with cardiac injury among hospitalized patients with COVID-19

tetano

Editor, Senior Moderator
Sci Rep


. 2021 Feb 24;11(1):4432.
doi: 10.1038/s41598-021-83822-9.
Association of coagulation dysfunction with cardiac injury among hospitalized patients with COVID-19


Liang Chen[SUP] #[/SUP][SUP] 1 [/SUP], Wei Hu[SUP] #[/SUP][SUP] 2 [/SUP], Xiaoxiao Guo[SUP] #[/SUP][SUP] 2 [/SUP], Ping Zhao[SUP] 3 [/SUP], Jia Tang[SUP] 2 [/SUP], Yuwei Gu[SUP] 2 [/SUP], Ninghao Huang[SUP] 3 [/SUP], Chao Wang[SUP] 2 [/SUP], An Cui[SUP] 2 [/SUP], Dian Zhang[SUP] 2 [/SUP], Linjie Hu[SUP] 3 [/SUP], Yi Feng[SUP] 4 [/SUP], Shengshou Hu[SUP] 1 [/SUP], Mingquan Chen[SUP] 5 [/SUP], Firat Duru[SUP] 6 7 [/SUP], Chenglong Xiong[SUP] 8 9 [/SUP]



Affiliations

Abstract

Cardiac injury is a common complication of the coronavirus disease 2019 (COVID-19), and is associated with adverse clinical outcomes. In this study, we aimed to reveal the association of cardiac injury with coagulation dysfunction. We enrolled 181 consecutive patients who were hospitalized with COVID-19, and studied the clinical characteristics and outcome of these patients. Cardiac biomarkers high-sensitivity troponin I (hs-cTnI), myohemoglobin and creatine kinase-myocardial band (CK-MB) were assessed in all patients. The clinical outcomes were defined as hospital discharge or death. The median age of the study cohort was 55 (IQR, 46-65) years, and 102 (56.4%) were males. Forty-two of the 181 patients (23.2%) had cardiac injury. Old age, high leukocyte count, and high levels of aspartate transaminase (AST), D-dimer and serum ferritin were significantly associated with cardiac injury. Multivariate regression analysis revealed old age and elevated D-dimer levels as being strong risk predictors of in-hospital mortality. Interleukin 6 (IL6) levels were comparable in patients with or without cardiac injury. Serial observations of coagulation parameters demonstrated highly synchronous alterations of D-dimer along with progression to cardiac injury. Cardiac injury is a common complication of COVID-19 and is an independent risk factor for in-hospital mortality. Old age, high leukocyte count, and high levels of AST, D-dimer and serum ferritin are significantly associated with cardiac injury, whereas IL6 are not. Therefore, the pathogenesis of cardiac injury in COVID-19 may be primarily due to coagulation dysfunction along with microvascular injury.
 
Back
Top Bottom